Fluorescence-guided surgery for oral cancer
Part of Cancer, Mouth & dental clinical trials.
This Phase 2 trial tests a special light-tracking medicine (cRGD-ZW800-1) to help surgeons see oral cancer during surgery. The goal is to improve how well the tumor is found and removed while keeping side effects manageable.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have biopsy-confirmed squamous cell cancer in the mouth (oral cavity).
- You are 18 years or older and planning surgery to remove the main tumor.
- You can give informed consent before starting the study.
- You have no major heart rhythm problem on ECG and no major lab abnormalities (or they’re judged not important).
- You have not had prior surgery, chemotherapy, or radiation to the mouth area.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to give an immunotherapy drug called nivolumab before surgery for head and neck cancer. The drug is injected directly into the tumor and is labeled with a fluorescent marker so researchers can see how it works in the removed tissue. This might help improve treatment for future patients.
This trial tests if giving a short course of radiation (SBRT) along with chemotherapy and an immunotherapy drug before surgery can improve outcomes for people with advanced mouth or throat cancer that is not caused by HPV. It's designed for patients whose tumors can be surgically removed and who haven't had prior cancer treatment.
This study tests a special dye/light method during surgery for laryngeal and hypopharyngeal squamous cell cancer. The goal is to see if it’s safe and practical to help surgeons find the tumor more clearly.
This Phase 2 study tests a special camera and dye during surgery to help surgeons confirm they removed all cancer at the edge of the removed tissue. If it works, it may lower the chance of cancer being left behind after oral cavity or oropharynx squamous cell cancer surgery.
This Phase 2 study tests medicines given before surgery for stage III/IV oral squamous cell carcinoma, choosing the treatment based on your tumor marker results. It aims to shrink the cancer and improve outcomes by using two targeted types of therapy.
This Phase 2 trial tests a chemotherapy plan given first (before surgery) for people with oral squamous cell carcinoma that has specific cancer markers and lymph node involvement. It aims to shrink or control the cancer so treatment after may work better.
Hear when a new Oral Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.